Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer
Clinical trial NCT05909397 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05909397
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-09
- Primary completion
- 2026-12-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.